Michael S. Gunter, Interim CEO at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 5,000 shares at $2.65 ($13K) on 2012-12-17, disclosed to the SEC on 2012-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.65 | 46 | $122 | 0.9% |
| 2 | $2.65 | 1,625 | $4K | 32.9% |
| 3 | $2.60 | 3,329 | $9K | 66.2% |
| Total | $2.62 avg | 5,000 | $13K | 100% |
| Filing → |
| HRT | BUY | 2012-02-14 | $1K | — | Filing → |
| HRT | BUY | 2011-12-15 | $2K | — | Filing → |
| HRT | BUY | 2011-11-30 | $8K | — | Filing → |